Business Context and Reporting Period
Park Ha Biological Technology Co., Ltd., a Cayman Islands exempted company with principal executive offices in Wuxi, China, filed this Form 6-K for the month of January 2026. The filing reports the pricing and closing of a best-efforts follow-on public offering.
Key Financial Metrics
- Gross Proceeds: Approximately US$2.45 million.
- Offering Price: US$0.112 per Unit.
- Units Sold: 21,875,000 Units (each consisting of one Class A Ordinary Share and one Warrant).
- Placement Agent Fee: 7.0% of aggregate gross proceeds.
- Warrant Terms: Exercise price of US$0.112; exercisable immediately through the one-year anniversary of issuance.
The filing does not provide specific values for revenue, profit, cash flow, operating margins, total debt, or liquidity ratios as this is a transaction-specific report rather than a periodic financial statement.
Material Changes
The primary material change is the increase in equity capital following the closing of the Offering on January 28, 2026. The company raised approximately US$2.45 million in gross proceeds, subject to deductions for placement agent commissions and offering expenses. No comparative financial data for prior periods is included in this filing.
Guidance, Outlook, and Use of Proceeds
Management intends to use the net proceeds from the Offering for the expansion of directly operated stores in China. The specific allocation of funds to each market will be determined based on prevailing market conditions. The filing does not contain forward-looking financial guidance or specific risk factors beyond standard securities law disclaimers.
Investor Verification Checklist
- Verify the final net proceeds after deducting the 7.0% placement agent fee and other offering expenses.
- Confirm the exact number of Units sold versus the aggregate 21,875,000 Units announced, as this was a best-efforts offering.
- Review the attached Placement Agency Agreement (Exhibit 10.1) for expense reimbursement caps.
- Monitor the company's subsequent filings for the actual deployment of funds into store expansion in China.